Medical Retina Services      

FOI REFERENCE: 24536  FOI DATE: 20^th November 2024    

Regional / system wide picture of medical retina services – Wet AMD and other anti VEGf treated condition, covering demand, capacity, and delivery.

Such information should be obtained via the ICB the trust does not have regional data.

For the financial years 2022/23, 2023/24 and current YTD, how many referrals have you received for wet AMD, diabetic macular oedema and retinal vein occlusion (Anti VEGf services) or perhaps referred to as medical retina?

Financial Years	Referrals
2024/2025	3264
2023/2024	7140
2022/2023	9992

For the financial years 2022/23, 2023/24 and current YTD, how many referrals have you rejected as unsuitable or undeliverable by your Trust?

Information not held electronically.

For the financial years 2022/23, 2023/24 and current YTD, how many referrals have you received, triaged, booked and completed first assessment and treatment within the 2-week RTT advised by NICE and the college of ophthalmologists? We are looking for your Trust performance data against the 14-day standard as a % by month for the periods – 2023/24 and 2024/25

Month	Number within 14 days	% within 14 days
Apr-22	15	22%
May-22	11	20%
Jun-22	20	16%
Jul-22	10	12%
Aug-22	25	30%
Sep-22	14	18%
Oct-22	64	50%
Nov-22	87	98%
Dec-22	71	91%
Jan-23	84	90%
Feb-23	82	94%
Mar-23	38	67%
Apr-23	24	39%
May-23	16	19%
Jun-23	29	29%
Jul-23	24	20%
Aug-23	28	26%
Sep-23	28	24%
Oct-23	43	34%
Nov-23	27	29%
Dec-23	32	16%
Jan-24	48	25%
Feb-24	29	14%
Mar-24	88	34%
Apr-24	170	79%
May-24	173	98%
Jun-24	320	97%
Jul-24	320	94%
Aug-24	276	75%
Sep-24	128	33%
Oct-24	140	30%
Nov-24	95	28%

How many patients are currently on a waiting list for an appointment for first assessment and or treatment? How many have breached the 2-week RTT?  

Total	Over 2 weeks
1947	1

How many patients are currently on a waiting list for a follow up appointment and treatment? How many of these have waited longer than the requested call back date stated as an outcome of their last assessment? (Ie overdue?) How many are overdue by more than one month? (We exclude from this any patients who have cancelled / DNA’s or are unable to attend an appointment that has been offered)

Total	Overdue Target Date
254	15

Which drugs are your preferred for a new patient? Which drugs do you still use for follow-up patients?

Biosimilar Ranibizumab (Ongavia)

Aflibercept (Eylea) 2 or 8 mg

Farcimab 6 mg (Vabysmo)

Bevacizumab (Avastin) in non-NICE approved conditions

Does your trust follow a see and treat “one stop” clinic format?  

Yes: most patients who attend on a Wednesday morning RAC are seen and treated on the same day.  If patients are seen in RAC on another day or seen in another clinic (Acutes etc) they are not (always) seen and treated the same day.  We are only set up for ‘one stop’ RAC clinics on Wednesday mornings

Does your trust follow treat and extend protocols where clinically appropriate?  

Yes, we follow treat & extend protocols where clinical appropriate (and for most of our patients)

How many patients have you certificated as sight impaired or severely sight impaired in the FYs 2022/23, 2023/24 and year to date due to Wet AMD?

Information not held electronically.